We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Albemarle (ALB) Dipped More Than Broader Market Today
Read MoreHide Full Article
In the latest close session, Albemarle (ALB - Free Report) was down 1.78% at $142.01. This change lagged the S&P 500's daily loss of 0.14%. On the other hand, the Dow registered a loss of 0.2%, and the technology-centric Nasdaq decreased by 0.24%.
The specialty chemicals company's shares have seen an increase of 12.66% over the last month, surpassing the Basic Materials sector's gain of 4.09% and the S&P 500's gain of 0.94%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company is expected to report EPS of -$0.61, up 44.04% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.37 billion, up 11.18% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.09 per share and revenue of $5.08 billion, indicating changes of +53.42% and -5.5%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 10.43% higher. Albemarle is currently a Zacks Rank #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 222, finds itself in the bottom 11% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Albemarle (ALB) Dipped More Than Broader Market Today
In the latest close session, Albemarle (ALB - Free Report) was down 1.78% at $142.01. This change lagged the S&P 500's daily loss of 0.14%. On the other hand, the Dow registered a loss of 0.2%, and the technology-centric Nasdaq decreased by 0.24%.
The specialty chemicals company's shares have seen an increase of 12.66% over the last month, surpassing the Basic Materials sector's gain of 4.09% and the S&P 500's gain of 0.94%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company is expected to report EPS of -$0.61, up 44.04% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.37 billion, up 11.18% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.09 per share and revenue of $5.08 billion, indicating changes of +53.42% and -5.5%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 10.43% higher. Albemarle is currently a Zacks Rank #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 222, finds itself in the bottom 11% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.